ZA
DGX icon

Zweig Advisers’s Quest Diagnostics DGX Stock Holding History

Zweig Advisers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-56,000
Closed -$4.3M – 73
2015
Q1 		$4.3M Buy
+56,000
New +$4.01M 0.62% 53

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Zweig Advisers's DGX Position: Q2 2015 in Review

Zweig Advisers sold out of Quest Diagnostics (DGX) in Q2 2015, closing a stake of 56,000 shares — an estimated $4.3M sold.

Zweig Advisers first reported a position in DGX in Q1 2015 and held it in 1 quarter. The position peaked at $4.3M in Q1 2015. 542 funds tracked by Wall St. Rank hold DGX as of Q2 2015.

  • Zweig Advisers reported no remaining Quest Diagnostics position as of Q2 2015 after selling out during the quarter.
  • Zweig Advisers sold 56,000 Quest Diagnostics shares in Q2 2015, an estimated $4.3M.
  • Zweig Advisers first reported a position in Quest Diagnostics in Q1 2015 and held it in 1 quarter.
  • Zweig Advisers's Quest Diagnostics position peaked at $4.3M in Q1 2015.
  • 542 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2015.

Based on Zweig Advisers's 13F filing for Q2 2015, filed 13 Aug 2015.